Bempegaldesleukin (NKTR-214): A CD-122-biased IL-2 Receptor Agonist for Cancer Immunotherapy
Expert Opinion on Biological Therapy - United Kingdom
doi 10.1080/14712598.2019.1685489
Full Text
Open PDFAbstract
Available in full text
Date
October 31, 2019
Authors
Publisher
Informa UK Limited